Journal
Journal for ImmunoTherapy of Cancer
Publication Date
3-1-2023
Volume
11
Issue
3
First Page
e005920
Document Type
Open Access Publication
DOI
10.1136/jitc-2022-005920
Rights and Permissions
Rizvi N, Ademuyiwa FO, Cao ZA, Chen HX, Ferris RL, Goldberg SB, Hellmann MD, Mehra R, Rhee I, Park JC, Kluger H, Tawbi H, Sullivan RJ. Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy. J Immunother Cancer. 2023 Mar;11(3):e005920. doi: 10.1136/jitc-2022-005920. © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Rizvi, Naiyer; Ademuyiwa, Foluso O.; Cao, Z Alexander; Chen, Helen X.; Ferris, Robert L.; Goldberg, Sarah B.; Hellmann, Matthew D.; Mehra, Ranee; Rhee, Ina; Park, Jong Chul; Kluger, Harriet; Tawbi, Hussein; and Sullivan, Ryan J., "Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy." Journal for ImmunoTherapy of Cancer. 11, 3. e005920 (2023).
https://digitalcommons.wustl.edu/oa_4/1356
Department
ICTS (Institute of Clinical and Translational Sciences)
